FY 2022 Q2 Earnings Trend Down, but Much Less than Predicted
While not nearly as robust as a year ago, diagnostic companies’ revenues held up surprisingly well in Q2 2022.
While not nearly as robust as a year ago, diagnostic companies’ revenues held up surprisingly well in Q2 2022.
Recent study suggests a new test may help doctors detect Lyme disease during the early stages when treatment is likely to be more effective.
A recent study shows that most patients who underwent such screening were diagnosed at an earlier stage than those who did not.
A recent study shows that just before you leave for a social event is best when it comes to testing for COVID-19.
The market is expected to grow at a CAGR of 3.21 percent from 2021 to 2028 and reach $17.432 billion by 2028, according to a recent report.